Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
Maxime Taquet(Mansfield University), Linzy Houchen-Wolloff(American Thoracic Society), Marco Sereno(University of Leicester), Amisha Singapuri(University of Leicester), Alex Horsley(University of Manchester), Annemarie B Docherty(Edinburgh Royal Infirmary), Betty Raman(John Radcliffe Hospital), Adam Hampshire(Western University), Ruth Saunders(University of Leicester), Jennifer K Quint(Roland Hill (United Kingdom)), Omer Elneima(University of Leicester), Christopher E. Brightling(University of Leicester), Michael Marks(American Heart Association), Paul J. Harrison(University of British Columbia), Hamish McAuley(University of Leicester), James D. Chalmers(University of Dundee), Louise V. Wain(University of Leicester), Rachael A Evans(University of Leicester), John Geddes(University of Oxford), Ewen M. Harrison(Centre for Inflammation Research), Olivia C. Leavy(University of Leicester), Naveed Sattar(University of Glasgow), Ling‐Pei Ho(University of Oxford), Nazir Lone(University of Edinburgh), Neil Greening(University of Leicester), Zuzanna Skórniewska(University of Oxford), Parisa Mansoori(MQ: Transforming Mental Health), Aarti Shikotra(University of Leicester), Matthew Richardson(University of Leicester), Victoria Harris(University of Leicester), Krisnah Poinasamy(Asthma UK)
Cited by 96
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.4k